0001213900-20-023899.txt : 20200826
0001213900-20-023899.hdr.sgml : 20200826
20200826181605
ACCESSION NUMBER: 0001213900-20-023899
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200824
FILED AS OF DATE: 20200826
DATE AS OF CHANGE: 20200826
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fairbairn Malcolm
CENTRAL INDEX KEY: 0001317314
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39102
FILM NUMBER: 201138421
MAIL ADDRESS:
STREET 1: C/O ASCEND CAPITAL, LLC
STREET 2: 4 ORINDA WAY, SUITE 200-C
CITY: ORINDA
STATE: CA
ZIP: 94563
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TFF Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001733413
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 824344737
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2600 VIA FORTUNA, SUITE 360
CITY: AUSTIN
STATE: TX
ZIP: 78746
BUSINESS PHONE: 737-802-1973
MAIL ADDRESS:
STREET 1: 2600 VIA FORTUNA, SUITE 360
CITY: AUSTIN
STATE: TX
ZIP: 78746
4
1
ownership.xml
X0306
4
2020-08-24
0
0001733413
TFF Pharmaceuticals, Inc.
TFFP
0001317314
Fairbairn Malcolm
2600 VIA FORTUNA, SUITE 360
AUSTIN
TX
78746
1
0
0
0
Stock Options (Right to Buy)
13.65
2020-08-24
4
A
0
13200
0.00
A
Common Stock
13200
105455
D
Each Option shall vest and first become exercisable as follows: one-quarter of the Option shall vest and first become exercisable on August 24, 2021 and the remainder of the Option shall vest and first become exercisable in 12 equal quarterly installments commencing on November 24, 2021.
/s/ Malcolm P. Fairbairn
2020-08-26